Water workouts may reverse Age-Related muscle decline

NCT ID NCT07575958

Recruiting now Symptom relief Sponsor: Gaziosmanpasa Research and Education Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 07, 2026 · Updated 3 times

Summary

This study tests whether a 6-week supervised pool exercise program can improve muscle strength, mass, and quality of life in adults aged 65 and older with sarcopenia (age-related muscle loss). Participants will do 15 sessions of water-based exercises over 6 weeks. Researchers will measure muscle thickness, strength, and physical performance before, after, and one month later.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Aquatic exercise program (pool-based exercises)
What this could lead to: If it works, this could offer a safe, effective way for older adults with sarcopenia to improve muscle strength and quality of life without the challenges of land-based exercise.
What could go wrong: This is a small, early-stage trial with only 44 participants, so results may not apply to everyone. The program is short (6 weeks), and benefits might not last long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOPENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SARCOPENIA SARCOPENIA IN ELDERLY

Contacts and locations

Locations

Gaziosmanpasa Research and Education Hospital
RECRUITING

Istanbul, Istanbul, 34255, Turkey (Türkiye)
University of Health Sciences Gaziosmanpaşa Training and Research Hospital
RECRUITING

Istanbul, Istanbul, 34255, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.